Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial for Second Line Treatment of Acute DVT With Endovascular Interventional Treatments

NCT06486181 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT06486181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06486181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial for Second Line Treatment of Acute DVT With Endovascular Interventional Treatments
Lead sponsor
Rush University Medical Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
April 30, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep venous thrombosis